Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

Trial Profile

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Prasugrel (Primary)
  • Indications Acute coronary syndromes; Myocardial infarction; Thrombosis
  • Focus Pharmacodynamics
  • Acronyms TTISUE
  • Most Recent Events

    • 09 Apr 2016 According to ClinicalTrials.gov record,study design is changed from non-randomised to randomised and treatment arms changed from 1 to 2.
    • 09 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Oct 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top